These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
286 related items for PubMed ID: 8355197
1. Alterations in vascular structure and function after short-term losartan treatment in spontaneously hypertensive rats. Soltis EE. J Pharmacol Exp Ther; 1993 Aug; 266(2):642-6. PubMed ID: 8355197 [Abstract] [Full Text] [Related]
2. Acute and chronic effects of losartan (DuP 753) on blood pressure and vascular reactivity in normotensive rats. Soltis EE, Jewell AL, Dwoskin LP, Cassis LA. Clin Exp Hypertens; 1993 Jan; 15(1):171-84. PubMed ID: 8467311 [Abstract] [Full Text] [Related]
3. Acute myocardial and vascular responses to specific angiotensin II antagonism in the spontaneously hypertensive rat. Cody RJ, Binkley PF, Haas GJ, Brown DM. Am J Hypertens; 1995 May; 8(5 Pt 1):500-8. PubMed ID: 7662227 [Abstract] [Full Text] [Related]
4. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. Levy BI, Benessiano J, Henrion D, Caputo L, Heymes C, Duriez M, Poitevin P, Samuel JL. J Clin Invest; 1996 Jul 15; 98(2):418-25. PubMed ID: 8755652 [Abstract] [Full Text] [Related]
13. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review. Dahlöf B. J Hum Hypertens; 1995 Nov 27; 9 Suppl 5():S37-44. PubMed ID: 8583480 [Abstract] [Full Text] [Related]
14. Changes in the composition of the thoracic aortic wall in spontaneously hypertensive rats treated with losartan or spironolactone. Han WQ, Wu LY, Zhou HY, Zhang J, Che ZQ, Wu YJ, Liu JJ, Zhu DL, Gao PJ. Clin Exp Pharmacol Physiol; 2009 May 27; 36(5-6):583-8. PubMed ID: 19673944 [Abstract] [Full Text] [Related]
15. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists. Cosentino F, Savoia C, De Paolis P, Francia P, Russo A, Maffei A, Venturelli V, Schiavoni M, Lembo G, Volpe M. Am J Hypertens; 2005 Apr 27; 18(4 Pt 1):493-9. PubMed ID: 15831358 [Abstract] [Full Text] [Related]
16. Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats. Peiró C, Llergo JL, Angulo J, López-Novoa JM, Rodríguez-López A, Rodríguez-Mañas L, Sánchez-Ferrer CF. Br J Pharmacol; 1997 Aug 27; 121(7):1438-44. PubMed ID: 9257925 [Abstract] [Full Text] [Related]
17. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis]. Gouédard O, Gaudet E, Blanc J, Ponchon P, Elghozi JL. Arch Mal Coeur Vaiss; 1996 Aug 27; 89(8):1013-7. PubMed ID: 8949370 [Abstract] [Full Text] [Related]
19. Angiotensin II receptor antagonist losartan has persistent effects on blood pressure in the young spontaneously hypertensive rat: lack of relation to vascular structure. Morton JJ, Beattie EC, MacPherson F. J Vasc Res; 1992 Apr 27; 29(3):264-9. PubMed ID: 1387008 [Abstract] [Full Text] [Related]
20. Effects of chronic treatment with losartan on blood pressure, endothelin-like immunoreactivity and nitric oxide in normotensive rats. Sacerdote A, Cosenzi A, Bocin E, Molino R, Seculin P, Plazzotta N, Luxich E, Bellini G. J Hypertens; 1995 Dec 27; 13(12 Pt 2):1670-3. PubMed ID: 8903630 [Abstract] [Full Text] [Related] Page: [Next] [New Search]